Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 220
8
Diseases
9
Unique genes
0.220
Avg. similarity score
Cortical dysplasia
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Cortical dysplasia
Developmental delay with language impairment and movement disorder
Intellectual developmental disorder autism speech
Cortical occipital malformations
Intellectual developmental disorder speech autism dysmorphic
Intellectual developmental disorder language neurodegenerative
intellectual developmental disorder with autistic features and language delay, with or without seizures
lethal osteosclerotic bone dysplasia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cortical dysplasia | 5 | 5 | 4 |
| Developmental delay with language impairment and movement disorder | 5 | 5 | 2 |
| Intellectual developmental disorder autism speech | 5 | 5 | 2 |
| Cortical occipital malformations | 4 | 4 | 2 |
| Intellectual developmental disorder speech autism dysmorphic | 4 | 4 | 3 |
| Intellectual developmental disorder language neurodegenerative | 1 | 1 | 1 |
| intellectual developmental disorder with autistic features and language delay, with or without seizures | 1 | 1 | 1 |
| lethal osteosclerotic bone dysplasia | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TBR1 | 5 / 8 | Cortical dysplasia, Cortical occipital malformations, Developmental delay with language impairment and movement disorder, Intellectual developmental disorder autism speech and 1 more |
| FAM20C | 2 / 8 | Cortical dysplasia, lethal osteosclerotic bone dysplasia |
| NR4A2 | 2 / 8 | Developmental delay with language impairment and movement disorder, Intellectual developmental disorder language neurodegenerative |
| TANC2 | 2 / 8 | Intellectual developmental disorder autism speech, intellectual developmental disorder with autistic features and language delay, with or without seizures |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Inhibition of TSC complex formation by PKB | Reactome | 1 / 3 | 445× | 2.25e-3 | 2.48e-2 ✓ sig. |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | Reactome | 1 / 20 | 66.7× | 1.49e-2 | 8.66e-2 |
| Deadenylation of mRNA | Reactome | 1 / 24 | 55.6× | 1.78e-2 | 9.67e-2 |
| Laminin interactions | Reactome | 1 / 28 | 47.7× | 2.08e-2 | 1.05e-1 |
| Energy dependent regulation of mTOR by LKB1-AMPK | Reactome | 1 / 29 | 46.0× | 2.15e-2 | 1.07e-1 |
| MET activates PTK2 signaling | Reactome | 1 / 30 | 44.5× | 2.23e-2 | 1.09e-1 |
| Human papillomavirus infection | KEGG | 2 / 333 | 8.0× | 2.43e-2 | 1.15e-1 |
| PI3K-Akt signaling pathway | KEGG | 2 / 361 | 7.4× | 2.82e-2 | 1.25e-1 |
| TBC/RABGAPs | Reactome | 1 / 46 | 29.0× | 3.40e-2 | 1.38e-1 |
| Nuclear Receptor transcription pathway | Reactome | 1 / 52 | 25.7× | 3.83e-2 | 1.48e-1 |
| Macroautophagy | Reactome | 1 / 68 | 19.6× | 4.98e-2 | 1.71e-1 |
| Non-small cell lung cancer | KEGG | 1 / 73 | 18.3× | 5.34e-2 | 1.78e-1 |
| RNA degradation | KEGG | 1 / 78 | 17.1× | 5.70e-2 | 1.84e-1 |
| TP53 Regulates Metabolic Genes | Reactome | 1 / 86 | 15.5× | 6.27e-2 | 1.93e-1 |
| ECM-receptor interaction | KEGG | 1 / 89 | 15.0× | 6.48e-2 | 1.96e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| adult locomotory behavior | GO:0008344 | 2 / 56 | 74.2× | 3.13e-4 | 6.93e-3 ✓ sig. |
| general adaptation syndrome | GO:0051866 | 1 / 1 | 2,076× | 4.82e-4 | 9.31e-3 ✓ sig. |
| specification of animal organ identity | GO:0010092 | 1 / 1 | 2,076× | 4.82e-4 | 9.31e-3 ✓ sig. |
| memory T cell differentiation | GO:0043379 | 1 / 1 | 2,076× | 4.82e-4 | 9.31e-3 ✓ sig. |
| cerebral cortex development | GO:0021987 | 2 / 88 | 47.2× | 7.73e-4 | 1.28e-2 ✓ sig. |
| osteoclast maturation | GO:0036179 | 1 / 2 | 1,038× | 9.63e-4 | 1.47e-2 ✓ sig. |
| regulation of phosphorus metabolic process | GO:0051174 | 1 / 2 | 1,038× | 9.63e-4 | 1.47e-2 ✓ sig. |
| anterograde dendritic transport of messenger ribonucleoprotein complex | GO:0098964 | 1 / 3 | 692× | 1.44e-3 | 1.87e-2 ✓ sig. |
| conditioned taste aversion | GO:0001661 | 1 / 3 | 692× | 1.44e-3 | 1.87e-2 ✓ sig. |
| habenula development | GO:0021986 | 1 / 3 | 692× | 1.44e-3 | 1.87e-2 ✓ sig. |
| amygdala development | GO:0021764 | 1 / 4 | 519× | 1.93e-3 | 2.20e-2 ✓ sig. |
| dense core granule cytoskeletal transport | GO:0099519 | 1 / 4 | 519× | 1.93e-3 | 2.20e-2 ✓ sig. |
| cellular response to decreased oxygen levels | GO:0036294 | 1 / 4 | 519× | 1.93e-3 | 2.20e-2 ✓ sig. |
| cellular response to corticotropin-releasing hormone stimulus | GO:0071376 | 1 / 5 | 415× | 2.41e-3 | 2.50e-2 ✓ sig. |
| organelle organization | GO:0006996 | 1 / 5 | 415× | 2.41e-3 | 2.50e-2 ✓ sig. |